Helix
PrivateLast Round
Series C
Jun 3, 2021
Total Funding Raised
$383.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Helix operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Series C round in June 2021.
Helix is a genomics and data analytics company that provides actionable genetic insights and conducts large-scale genetic analysis to enhance patient care and public health decision-making.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Helix Comparables
Compare Helix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempus | 78% | |
| SOPHiA GENETICS | 76% | |
| DNAnexus | 76% |
For institutional investors. Book with your work email.
Helix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 3, 2021 | ||||
| Grant | Jul 31, 2020 | ||||
| Series B | Mar 1, 2018 | ||||
| Series A | Aug 18, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Helix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series B, Series C |
| NIH RADx | Grant |
| DFJ Growth | Series B, Series C |
| Warburg Pincus | Series B, Series A, Series C |
| Venrock | Series B |
| Kleiner Perkins | Series B, Series C |
| Sutter Hill Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
Clinical laboratory has achieved CAP accreditation.
- May 7, 2026
Clinical laboratory has received CLIA certification.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientNov 2, 2026
Mayo Clinic International selects Helix as its multi-omic lab provider and AI tools partner for Precure, with Helix providing clinical whole-genome sequencing, research-grade multi-omics data from approximately one million biospecimens, and AI tools for research and clinical workflows.
- launchesOct 22, 2026
Helix launches the Uniquely You genetic screening initiative in New York on Oct 22nd '26, with enrollment set to begin in early 2027.
- partners_withSep 24, 2026
Helix and Databricks Inc. partner to launch Helix Research Workspaces, a governed environment that gives approved research partners secure access to tools and compute for more than 550,000 linked clinicogenomic records in California on Sep 24th '26.
- signs_new_clientSep 21, 2026
On Sep 21st '26, Pre-Cure selects Helix as its multiomic laboratory and AI tools provider to support plans to generate molecular data from approximately one million biospecimens.
- launchesSep 10, 2026
Helix launches whole exome+(r) sequencing in California on Sep 10th '26, bringing exome, mitochondrial, and chromosomal analysis together in a single order for patients with rare and unexplained genetic conditions.
For institutional investors. Book with your work email.
Helix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Helix's valuation, stock price, and market status.
Is Helix a public or private company?
Helix is a private company.
What is the current stock price of Helix?
Helix is a private company, so its shares have no public market price. Caplight tracks Helix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Helix worth (valuation)?
Valuation information for Helix is not publicly available.
Can I buy Helix stock?
Helix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Helix's last funding round?
Helix's most recent funding round was Series C on June 3, 2021.
Who are the main investors in Helix?
Key investors in Helix include Temasek, DFJ Growth, Warburg Pincus, Kleiner Perkins.
Will Helix IPO soon?
No public IPO plans have been announced for Helix.
How can I track Helix secondary market activity?
Caplight tracks bids, offers, and trades in Helix's shares on secondary markets.